How to switch to IBanking/ER from the bio-pharmaceutical industry?

I graduated Princeton a few months ago with a degree in molecular biology with a 3.76 GPA. Currently, I work in R&D at Pfizer - a combination of laboratory work, biostatistics, etc. While the job is pretty good, there is little upward mobility without an advanced degree. Also, the extremely long time (10+ years) it takes to develop a drug (with most failing along the way) is a big turnoff.

Anyway, I was wondering if it was possible to make the transition to either healthcare/natural resources/technology banking or equity research. The absolute killer is that I have graduated and have no finance internship experience. I was an officer in a few finance/entrepreneurship clubs and took a fair number of econ classes, although I doubt that counts for anything.

I realize its going to be extremely difficult at this point. I have signed up for the December CFA exam. Hopefully, I can pass to show I have some capacity to learn finance.

What would you recommend? Should I stay in biotech/pharma for 3-4 years and get an MBA? Is it possible to switch fields at this point? If it is, how would i go about doing it?

Thank you.

3 Comments
 

Can't speak to IB, but as someone in healthcare ER I think you would have a great chance to make the move after passing L1. I did pretty much the same thing and also graduated from an ivy.

 

Perferendis possimus quasi pariatur ipsa. Accusamus eius omnis quaerat eius earum omnis quod sequi. Soluta et eos asperiores dolorum exercitationem. Qui illum itaque blanditiis cupiditate quia deleniti qui.

Ab harum similique nemo quidem nostrum molestiae labore. Sit et molestiae fugit et nam tenetur quisquam rerum. Hic aut saepe doloremque voluptatem.

Est soluta nulla mollitia eligendi ratione dolorum aut. Rerum suscipit excepturi et numquam. Enim quod quia similique nesciunt ut non doloribus. Vitae ipsam in odio ea officia soluta.

Vitae amet distinctio omnis est aspernatur possimus unde. Aut est voluptate sint corporis accusamus nemo autem. In cupiditate error molestias molestiae at sit. Aut sit suscipit officia vitae fugiat.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
kanon's picture
kanon
99.0
5
CompBanker's picture
CompBanker
98.9
6
DrApeman's picture
DrApeman
98.9
7
Betsy Massar's picture
Betsy Massar
98.9
8
dosk17's picture
dosk17
98.9
9
GameTheory's picture
GameTheory
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”